-transparent.png){kind=logo}
Dialkyldithiocarbamates injected into mice 0.5 h prior to alloxan protected dose-dependently against the diabetogenic action of alloxan, and increased blood glucose levels at the time of alloxan injection. Furthermore, they exhibited anti-oxidative properties in vitro such as inhibition of lipid peroxidation, removal of hydrogen peroxide and reduction of the stable free radical, 1, 1-diphenyl-2-picrylhydrazyl (DPPH). These results suggest that dialkyldithiocarbamates protect against the development of alloxan-induced diabetes by the indirect mechanism of producing hyperglycemia at the time of alloxan injection and possibly by their anti-oxidative effects as well.
Related Publications
T Masukawa, and
K Nakanishi, and
J Katakawa, and
T Tetsumi
March 1947,
The Anatomical record,
T Masukawa, and
K Nakanishi, and
J Katakawa, and
T Tetsumi
May 1962,
Archives of pathology,
T Masukawa, and
K Nakanishi, and
J Katakawa, and
T Tetsumi
July 1955,
Metabolism: clinical and experimental,
T Masukawa, and
K Nakanishi, and
J Katakawa, and
T Tetsumi
January 1988,
Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas,
T Masukawa, and
K Nakanishi, and
J Katakawa, and
T Tetsumi
November 1954,
Science (New York, N.Y.),
T Masukawa, and
K Nakanishi, and
J Katakawa, and
T Tetsumi
March 1955,
Science (New York, N.Y.),
T Masukawa, and
K Nakanishi, and
J Katakawa, and
T Tetsumi
February 1953,
Science (New York, N.Y.),
T Masukawa, and
K Nakanishi, and
J Katakawa, and
T Tetsumi
November 1978,
European journal of pharmacology,
T Masukawa, and
K Nakanishi, and
J Katakawa, and
T Tetsumi
November 1979,
The Journal of pharmacology and experimental therapeutics,
T Masukawa, and
K Nakanishi, and
J Katakawa, and
T Tetsumi
January 1995,
Physiological chemistry and physics and medical NMR,
